Weight Loss Drug Can Benefit Those With Diabetes, Heart Failure

A study published in the New England Journal of Medicine shows that the weight loss drug Wegovy may offer health benefits beyond just helping people lose weight. It particularly benefits individuals with Type 2 diabetes who also have a common type of heart failure called obesity-related heart failure with preserved ejection fraction. This is another… Continue reading Weight Loss Drug Can Benefit Those With Diabetes, Heart Failure

Sweetened Beverages Linked to Increased Heart Risk

In a recently published study, researchers shed light on a concerning link between sweetened beverage consumption and atrial fibrillation (A-fib). This is a potentially dangerous heart risk characterized by an irregular heartbeat. Atrial fibrillation is a serious health concern. It is known to lead to complications such as stroke, blood clots, and heart failure. It… Continue reading Sweetened Beverages Linked to Increased Heart Risk

Weight-loss Drug Shown To Reduce Risk of Heart Conditions

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s application to include cardiovascular benefits on the label of Wegovy, a weight-loss drug. This makes Wegovy the first weight-loss medication authorized to reduce the risk of heart attack, stroke, or heart-related death in individuals at higher risk for these conditions. The label expansion could… Continue reading Weight-loss Drug Shown To Reduce Risk of Heart Conditions